Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2026)

Akebia Therapeutics (AKBA) has 10 years of Asset Utilization Ratio data on file, last reported at 0.63 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.63, down 9.73% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.63 (down 9.73% YoY), and the FY2025 annual result was 0.79, up 14.16% from the prior year.
• Asset Utilization Ratio eased to 0.63 in Q1 2026 per AKBA's latest filing, from 0.64 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.82 in Q4 2023 and troughed at 0.04 in Q3 2022.
• A 5-year average of 0.57 and a median of 0.64 in 2025 frame the typical range for Asset Utilization Ratio.
• On a YoY basis, Asset Utilization Ratio climbed as much as 13978.54% in 2022 and fell as far as 115.16% in 2022.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.47 in 2022, then surged by 72.72% to 0.82 in 2023, then fell by 8.29% to 0.75 in 2024, then decreased by 14.83% to 0.64 in 2025, then dropped by 1.39% to 0.63 in 2026.
• Business Quant data shows AKBA's Asset Utilization Ratio at 0.63 in Q1 2026, 0.64 in Q4 2025, and 0.63 in Q3 2025.